Novel peptides that bind to the erythropoietin receptor

Details Novel peptides that bind to the erythropoietin receptor Novel peptides that bind to the erythropoietin receptor

C - Chemistry, Metallurgy

07

K

C07K 14/505 (2006.01) A61K 38/12 (2006.01) A61K 38/18 (2006.01) C07K 7/64 (2006.01) C07K 14/71 (2006.01)

Patent

CA 2525568

The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.

L'invention porte: sur des composés peptidiques agonistes du récepteur de l'érythropoïétine (EPO-R); sur des méthodes thérapeutiques utilisant lesdits composés pour traiter divers troubles associés à une production défectueuse ou insuffisante de globules rouges et sur des préparations pharmaceutiques comprenant lesdits composés.

Affiliated with

Also associated with

Rating

Novel peptides that bind to the erythropoietin receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel peptides that bind to the erythropoietin receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel peptides that bind to the erythropoietin receptor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1846790